PURPOSE: The complexity of results generated from whole-genome sequencing (WGS) and whole-exome sequencing (WES) adds challenges to obtaining informed consent in pediatric oncology. Little is known about knowledge of WGS and WES in this population, and no validated tools exist in pediatric oncology. METHODS: We developed and psychometrically evaluated a novel WGS and WES knowledge questionnaire, the Precision in Pediatric Sequencing Knowledge Questionnaire (PIPseqKQ), to identify levels of understanding among parents and young adult cancer survivors (≥ 18 years old), off therapy for at least 1 year from a single-institution pediatric oncology outpatient clinic. Participants also completed health literacy and numeracy questionnaires. All participants provided written informed consent. RESULTS: One hundred eleven participants were enrolled: 76 were parents, and 35 were young adults. Of the total cohort, 77 (69%) were female, 63 (57%) self-identified as white, and 74 (67%) self-identified as non-Hispanic. Sixty-six (59%) had less than a college degree. Adequate health literacy (n = 87; 80%) and numeracy (n = 89; 80%) were demonstrated. Internal consistency was high (Cronbach's α = .88), and test-retest reliability was greater than the 0.7 minimum requirement. Scores were highest for genetic concepts related to health and cancer and lowest for WGS and WES concepts. Health literacy and educational attainment were significantly associated with PIPseqKQ scores. Overall, participants felt the benefits of WGS and WES outweighed the potential risks. CONCLUSION: Parents and young adult cancer survivors have some genetics knowledge, but they lack knowledge about WGS and WES. The PIPseqKQ is a reliable tool that can identify deficits in knowledge, identify perceptions of risks and benefits of WGS and WES, and help clinicians tailor their consent discussions to best fit families. The PIPseqKQ also may inform the development of educational tools to better facilitate the informed consent process in pediatric oncology.
PURPOSE: The complexity of results generated from whole-genome sequencing (WGS) and whole-exome sequencing (WES) adds challenges to obtaining informed consent in pediatric oncology. Little is known about knowledge of WGS and WES in this population, and no validated tools exist in pediatric oncology. METHODS: We developed and psychometrically evaluated a novel WGS and WES knowledge questionnaire, the Precision in Pediatric Sequencing Knowledge Questionnaire (PIPseqKQ), to identify levels of understanding among parents and young adult cancer survivors (≥ 18 years old), off therapy for at least 1 year from a single-institution pediatric oncology outpatient clinic. Participants also completed health literacy and numeracy questionnaires. All participants provided written informed consent. RESULTS: One hundred eleven participants were enrolled: 76 were parents, and 35 were young adults. Of the total cohort, 77 (69%) were female, 63 (57%) self-identified as white, and 74 (67%) self-identified as non-Hispanic. Sixty-six (59%) had less than a college degree. Adequate health literacy (n = 87; 80%) and numeracy (n = 89; 80%) were demonstrated. Internal consistency was high (Cronbach's α = .88), and test-retest reliability was greater than the 0.7 minimum requirement. Scores were highest for genetic concepts related to health and cancer and lowest for WGS and WES concepts. Health literacy and educational attainment were significantly associated with PIPseqKQ scores. Overall, participants felt the benefits of WGS and WES outweighed the potential risks. CONCLUSION: Parents and young adult cancer survivors have some genetics knowledge, but they lack knowledge about WGS and WES. The PIPseqKQ is a reliable tool that can identify deficits in knowledge, identify perceptions of risks and benefits of WGS and WES, and help clinicians tailor their consent discussions to best fit families. The PIPseqKQ also may inform the development of educational tools to better facilitate the informed consent process in pediatric oncology.
Authors: Christopher A Cassa; Sarah K Savage; Patrick L Taylor; Robert C Green; Amy L McGuire; Kenneth D Mandl Journal: Genome Res Date: 2012-01-06 Impact factor: 9.043
Authors: Barbara C Worst; Cornelis M van Tilburg; Gnana Prakash Balasubramanian; Petra Fiesel; Ruth Witt; Angelika Freitag; Miream Boudalil; Christopher Previti; Stephan Wolf; Sabine Schmidt; Sasithorn Chotewutmontri; Melanie Bewerunge-Hudler; Matthias Schick; Matthias Schlesner; Barbara Hutter; Lenka Taylor; Tobias Borst; Christian Sutter; Claus R Bartram; Till Milde; Elke Pfaff; Andreas E Kulozik; Arend von Stackelberg; Roland Meisel; Arndt Borkhardt; Dirk Reinhardt; Jan-Henning Klusmann; Gudrun Fleischhack; Stephan Tippelt; Uta Dirksen; Heribert Jürgens; Christof M Kramm; Andre O von Bueren; Frank Westermann; Matthias Fischer; Birgit Burkhardt; Wilhelm Wößmann; Michaela Nathrath; Stefan S Bielack; Michael C Frühwald; Simone Fulda; Thomas Klingebiel; Ewa Koscielniak; Matthias Schwab; Roman Tremmel; Pablo Hernáiz Driever; Johannes H Schulte; Benedikt Brors; Andreas von Deimling; Peter Lichter; Angelika Eggert; David Capper; Stefan M Pfister; David T W Jones; Olaf Witt Journal: Eur J Cancer Date: 2016-07-29 Impact factor: 9.162
Authors: Samantha A Streicher; Saskia C Sanderson; Ethylin Wang Jabs; Michael Diefenbach; Meg Smirnoff; Inga Peter; Carol R Horowitz; Barbara Brenner; Lynne D Richardson Journal: J Community Genet Date: 2011-06-07
Authors: Phillip S Blanchette; Anna Spreafico; Fiona A Miller; Kelvin Chan; Jessica Bytautas; Steve Kang; Philippe L Bedard; Andrea Eisen; Larissa Potanina; Jack Holland; Suzanne Kamel-Reid; John D McPherson; Albiruni R Razak; Lillian L Siu Journal: Cancer Date: 2014-06-24 Impact factor: 6.860
Authors: Fiona A Miller; Robin Z Hayeems; Jessica P Bytautas; Philippe L Bedard; Scott Ernst; Hal Hirte; Sebastien Hotte; Amit Oza; Albiruni Razak; Stephen Welch; Eric Winquist; Janet Dancey; Lillian L Siu Journal: Eur J Hum Genet Date: 2013-07-17 Impact factor: 4.246
Authors: Michelle M Langer; Myra I Roche; Noel T Brewer; Jonathan S Berg; Cynthia M Khan; Cristina Leos; Elizabeth Moore; Michelle Brown; Christine Rini Journal: MDM Policy Pract Date: 2017-02-01
Authors: Marian H Harris; Steven G DuBois; Julia L Glade Bender; AeRang Kim; Brian D Crompton; Erin Parker; Ian P Dumont; Andrew L Hong; Dongjing Guo; Alanna Church; Kimberly Stegmaier; Charles W M Roberts; Suzanne Shusterman; Wendy B London; Laura E MacConaill; Neal I Lindeman; Lisa Diller; Carlos Rodriguez-Galindo; Katherine A Janeway Journal: JAMA Oncol Date: 2016-05-01 Impact factor: 31.777
Authors: Rajen J Mody; Yi-Mi Wu; Robert J Lonigro; Xuhong Cao; Sameek Roychowdhury; Pankaj Vats; Kevin M Frank; John R Prensner; Irfan Asangani; Nallasivam Palanisamy; Jonathan R Dillman; Raja M Rabah; Laxmi Priya Kunju; Jessica Everett; Victoria M Raymond; Yu Ning; Fengyun Su; Rui Wang; Elena M Stoffel; Jeffrey W Innis; J Scott Roberts; Patricia L Robertson; Gregory Yanik; Aghiad Chamdin; James A Connelly; Sung Choi; Andrew C Harris; Carrie Kitko; Rama Jasty Rao; John E Levine; Valerie P Castle; Raymond J Hutchinson; Moshe Talpaz; Dan R Robinson; Arul M Chinnaiyan Journal: JAMA Date: 2015-09-01 Impact factor: 56.272
Authors: Coren A Milbury; James Creeden; Wai-Ki Yip; David L Smith; Varun Pattani; Kristi Maxwell; Bethany Sawchyn; Ole Gjoerup; Wei Meng; Joel Skoletsky; Alvin D Concepcion; Yanhua Tang; Xiaobo Bai; Ninad Dewal; Pei Ma; Shannon T Bailey; James Thornton; Dean C Pavlick; Garrett M Frampton; Daniel Lieber; Jared White; Christine Burns; Christine Vietz Journal: PLoS One Date: 2022-03-16 Impact factor: 3.240